BioAdvance News InfraScan Portfolio News

InfraScan receives 2022 Life Sciences PA Patient Impact Award

By WebmasterMarch 22, 2023November 1st, 2024No Comments

InfraScan receives 2022 Life Sciences PA Patient Impact Award

InfraScan receives the Life Sciences PA Patient Impact Award for the second time.

Previous PostRelmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
Next PostClario and Strados Labs partner to bring new pulmonary endpoints to respiratory clinical trials